We explore the claim that administering ketorolac (Toradol) increases bleeding and should be avoided in surgeries for which there is concern for bleeding.
1. Administration of intraoperative ketorolac increases the bleeding time due to platelet inhibition
2. Increased bleeding time translates to higher rate of surgical bleeding
3. The magnitude of bleeding propensity attributable to ketorolac is clinically relevant
Our guest today is Dr. Jamie Sparling of the Critical Care Division of the Massachusetts General Hospital. Recommend a guest or topic at depthofanesthesia@gmail.com or tweet us @DepthAnesthesia.
Podcast: Play in new window | Download
